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Abstract
Background: There are limited series concerning Dieulafoy disease of the bronchus. We describe
the clinical presentation of a series of 7 patients diagnosed with Dieulafoy disease of the bronchus
and provide information about the pathological diagnosis approach.
Patients and methods: A retrospective review of patients who underwent surgery for massive
and unexplained recurrent hemoptysis in a referral center during a 11-year period.
Results: Seven heavy smoker (49 pack years) patients (5 males) mean aged 54 years experienced
a massive hemoptysis (350–1000 ml) unrelated to a known lung disease and frequently recurrent.
Bronchial contrast extravasation was observed in 3 patients, combining both CT scan and bronchial
arteriography. Efficacy of bronchial artery embolization was achieved in 40% of cases before
surgery. Pathological examination demonstrated a minute defect in 3 cases and a large and dysplasic
superficial bronchial artery in the submucosa in all cases.
Conclusion: Dieulafoy disease should be suspected in patients with massive and unexplained
episodes of recurrent hemoptysis, in order to avoid hazardous endoscopic biopsies and to alert
the pathologist if surgery is performed.
Background
Massive hemoptysis is a life threatening condition associ-
ated with a mortality rate exceeding 50% in the absence of
adequate treatment [1-3]. A standardized and prompt
management is required in emergency to improve sur-
vival, as well as a careful search of both the location and
the etiology of bleeding. More than one hundred causes of
massive hemoptysis have been described [4]. Neverthe-
less, no cause is identified in about 15% of the cases,
despite a complete investigation including fiberoptic
bronchoscopy and CT-scan [5,6].
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We have recently reported a few subset of patients with so-
called cryptogenic hemoptysis, in whom an unexpected
vascular abnormality was demonstrated at pathological
examination of the pulmonary resection, characterized by
a bronchial artery running within the submucosa and
called Dieulafoy disease of the bronchus [7]. Additionally,
only eight cases of bronchial Dieulafoy disease proved on
histological data in six case reports have been reported to
date [8-13]. To our knowledge, no case series have been
published from a tertiary referral center managing massive
hemoptysis.
The aim of our study was to report the clinical presenta-
tion of the patients who underwent surgery for massive
hemoptysis in our center and in whom a Dieulafoy dis-
ease of the bronchus was eventually diagnosed and to pro-
vide detailed information on the approach to
pathological diagnosis in this field.
Patients and methods
Study design
All the patients were recruited in a respiratory intensive
care unit of a 800-bed tertiary university hospital in Paris,
France, between May 1995 and July 2006. During the
study period, 810 patients were admitted to our unit for
hemoptysis, 111 of whom underwent surgery. Part of
those patients has already been reported from our group
[7,14]. The study was conducted according to the French
law which judged unnecessary ethical approval and
patient consent for such a retrospective analysis of medi-
cal records.
Diagnosis of Dieulafoy disease of the bronchus
The diagnosis of Dieulafoy disease of the bronchus was
clinically suspected in case of the need for surgery for mas-
sive hemoptysis with no identifiable cause after fiberoptic
bronchoscopy and CT-scan. Dieulafoy disease of the
bronchus was pathologically confirmed by the evidence
of an isolated and localized area of hemorrhage with no
underlying lung disease known to be associated with
bronchial systemic hypervascularization (such bron-
chiectasis) on macroscopic inspection plus the evidence
of an unusual large superficial bronchial artery located
into the submucosa, possibly extended through the
mucosa into the bronchus lumen with no vasculitis, aneu-
rysm or arteriosclerosis on microscopic examination.
Pathologic lung study
The lung samples (lobectomy) were processed in an uni-
form way by the same pathologist (MA), when Dieulafoy
disease was suspected. First, the fresh lung resection was
macroscopically examined. Macroscopic inspection con-
firmed the focal nature of the hemorrhage. Nodular
lesions, blebs, areas of induration and subpleural hyper-
vascularization were checked. Segmental and sub segmen-
tal bronchi were subsequently opened with chisel in the
absence of obvious etiology. The presence and the loca-
tion of blood cloths were identified. After careful washing,
bronchiectasis, bronchial inflammatory aspect and
tumoral obstruction were searched as well as mucosal
abnormalities, i.e. minute defect and ulceration. Second,
after formalin fixation, 3 mm thick serial sections were
performed perpendicularly to the axis of the suspected
bronchus previously identified by the presence of cloths,
focal areas of hemorrhage or mucosal abnormalities; the
same procedure was applied to the other bronchi for com-
parison. Samples of fixed tissue were processed into paraf-
fin block, perpendicularly to the bronchial axes. Third,
serial sections were performed on the paraffin block
focusing on the suspected bronchus until lesions were
found. Sections were stained with hematoxylin-eosin-
safran, and elastic stain (Miller stain) for vessel identifica-
tion.
Collection of patients' data
The following prospectively collected clinical data were
extracted from our data base and controlled with the
review of the medical charts: baseline demographics, drug
intake, comorbid conditions, severity of hemoptysis, clin-
ical presentation, laboratory tests, chest radiography,
fiberoptic bronchoscopy and CT scan, ICU management
and vital status at ICU discharge.
Results
Seven patients fulfilled the aforementioned criteria during
the 11-year study period.
Patients' characteristics
The patients (5 males) were aged 54.3 ± 11.5 years (range,
38 to 69 years). They were current heavy smokers (49 ±
28.5 packs/years); all but one were alcohol abusers. Two
had mild to moderate chronic obstructive pulmonary dis-
ease. One patient had a history of pulmonary tuberculo-
sis. Two patients were treated for systemic hypertension, 1
of whom had a history of a transient ischemic stroke and
unexplained intestinal bleeding (Additional file 1). A pre-
vious episode of hemoptysis had occurred in 5 patients, 3
of whom had previously received a bronchial artery
embolization (BAE). Of note, 1 patient (patient n°4) had
been managed in our center 19 months ago for a first epi-
sode of massive hemoptysis (amount of 400 ml). Four
fiberoptic bronchoscopies were necessary to locate the
bleeding in the left upper lobe, as CT scan showed bilat-
eral ground glasses. A successful BAE was performed. The
patient refused a secondary scheduled surgery despite the
staff decision.
The cumulative amount of bleeding ranged from 350 ml
to more than 1000 ml on admission to our unit. There
were, however, mild clinical and biological consequences
of the bleeding. Bedside chest X-ray was unremarkable.
High resolution (n = 5) or multidetector (n = 2) CT-scanRespiratory Research 2008, 9:58 http://respiratory-research.com/content/9/1/58
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angiography showed ground glass opacities in all patients,
that were isolated or associated with alveolar opacities (n
= 4). The upper lobes were mainly involved (n = 5). Of
note, a frank contrast media extravasation within the
lumen of the bronchus related to the focal hemorrhagic
area was evidenced using multidetector CT-scan angiogra-
phy (patient n°4). There was no lung parenchyma abnor-
mality suggestive of carcinoma, bronchiectasis or
tuberculosis. A flexible fiberoptic bronchoscopy was per-
formed within the first 24 hours of admission, to locate
both the side and site of the bleeding. Overall, 10 bron-
choscopic procedures were performed. A bilateral bron-
chial flooding by blood was evidenced in all patients. The
location of the bleeding was successfully performed after
bronchoscopic techniques in 5 patients.
Management
The therapeutic management was standardized, as
described elsewhere [14]. Bronchoscopic techniques were
attempted to control the bleeding, combining blood aspi-
ration and local instillation of cold saline lavage. Vaso-
constrictive agents were delivered bronchoscopically
(adrenalin, n = 4), intravenously (terlipressin, n = 1) or
both (n = 1). A BAE was first attempted in all patients tota-
ling 10 sessions before surgery (Figure 1). Technical fail-
ure of bronchial arteriography was related to failure of
canulation in 2 patients (patients n°1 & n°3) and ana-
tomical consideration in 2 others (patients n°5 & n°6).
All bronchial arteries draining the bleeding site were
enlarged without systemic to pulmonary artery shunting.
A frank contrast media extravasation into the bronchial
lumen was evidenced in 2 patients (patients n°2 & n°7).
Altogether, BAE was completed in 5 cases (4 patients) and
controlled the bleeding in 2 cases (2 patients). According
to the high initial amounts of bleeding, all the patients
were secondary referred for surgery after 6.7 ± 5.8 days
(median time 5 days). The lobe to remove, from which
the bleeding originated, was identified by the combina-
Bronchial arteriography efficacy Figure 1
Bronchial arteriography efficacy. ASA = anterior spinal artery; RBICT = right broncho-intercostal trunk.Respiratory Research 2008, 9:58 http://respiratory-research.com/content/9/1/58
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tion of clinical examination, chest X-ray, CT scan and
bronchoscopic findings. Bronchial arteriography was not
used for locating the bleeding.
Follow-up after surgery
All patients were alive at hospital discharge. Follow-up
data were available for a mean duration of 35 ± 30
months (range, 6 to 96 months) after surgery. All but one
patient (patient n°4) remained free of bleeding recurrence
during follow-up. This latter patient was treated success-
fully with BAE. The patient n°7 died from an ischemic
stroke 12 months later.
Pathological findings
Lung macroscopic examination located the pathological
area in all patients by showing a focal hemorrhagic area
within the parenchyma and identifying a localized clot in
the corresponding segmental (n = 5) or sub segmental
bronchus (n = 2) (Additional file 2). Moreover, a minute
bronchial mucosal defect was eventually observed (n = 3)
(Figure 2A). There was no evidence of bronchial or vascu-
lar chronic disease. The macroscopic inspection was unre-
markable, except blebs (patients n°1 & n°2) and nodular
mass (patient n°6) that were distant from the pathologi-
cal hemorrhagic area.
Microscopic examination revealed a large and dysplasic
superficial bronchial artery in the submucosa in all
patients beneath the cartilage (Figure 2B). Artery ulcera-
tion with rupture into the bronchial lumen was observed
in 3 patients (Figure 2C). The structure of the bronchial
artery appeared dysplastic with irregular thickness of the
wall, which was either fibrotic or rich in elastic fibrils and
had a tortuous appearance when cut at various angles.
These arteries appeared on Miller stain with a thick inter-
nal lamina and a thin external one, in favor of the bron-
chial nature of the artery (Figure 2D). Finally, we observed
(patient n°4) the material of embolization in the lumen
of the vessel in 1 patient (Figure 2B). The respiratory epi-
thelium was either clearly or slightly eroded and appeared
sometimes metaplastic, although the structure of the
bronchus remained normal. Of note, the nodular mass
aforementioned (patient n°6) was related to a granulo-
matous disease consistent with an old sarcoidosis. In
another patient (patient n°1) a deposit of amyloidal
structure was identified. Otherwise, histological examina-
tion was unremarkable. No evidence of chronic bronchial
or other vascular disease was identified. No microorgan-
isms were grown, after special staining and culture for
mycobacteria and fungi.
Discussion
Our study aimed at better describing the process for diag-
nosing the Dieulafoy disease of the bronchus, from the
clinical suspicion to the pathological confirmation, based
on a series of 7 patients who underwent surgery for mas-
sive hemoptysis in a referral center over a 11-year period.
The condition was clinically suspected in heavy smokers
with recurrent and unexplained episodes of massive
hemoptysis, characterized by amounts of bleeding both
high and rather disproportioned, as compared with those
usually reported in patients presumed to have a cryp-
togenic hemoptysis. Although there were no specific CT-
scan or angiographic criteria, the frequent findings of both
the direct and frank contrast media extravasation within
the suspected bronchial lumen and the enlarged aspect of
the bronchial artery without systemic to pulmonary artery
shunting were suggestive of the vascular anomaly. A sub-
sequent structured and rigorous pathological examination
of the surgical lung resection confirmed definitively the
diagnosis.
Dieulafoy disease is a vascular anomaly characterized by
the presence of a dysplastic artery in the submucosa. It was
first reported in the gastrointestinal tract, accounting for
up to 2% of the bleedings [15]. The disease has been
recently described in the respiratory tract [12]. However,
the incidence of the Dieulafoy disease of the bronchus is
unknown and probably slightly underestimated regarding
Pathological Findings Figure 2
Pathological Findings. Macroscopic view showing a 
minute defect within the bronchial tree (arrow) (A). Low-
power view showing the location of the vessel in the sub-
mucosa beneath the cartilage plate, and the presence of the 
material of embolization in the lumen (arrow) (B). High-
power view revealing the protrusion of the superficial vessel 
in the lumen with an ulceration and a squamous metaplasia of 
the epithelium (C). High power-view showing a dysplastic 
artery with elastic stain (Miller stain) (D).Respiratory Research 2008, 9:58 http://respiratory-research.com/content/9/1/58
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to the rigorous pathological procedure needed for estab-
lishing the diagnosis. In our experience, Dieulafoy disease
of the bronchus accounted for at least 6% of the patients
undergoing surgery for hemoptysis overall and up to 55%
of the patients undergoing surgery for hemoptysis pre-
sumed to be cryptogenic [7].
The diagnosis of Dieulafoy disease of the bronchus
should be suspected on the combination of history, clini-
cal features and imaging investigations in order to con-
sider surgical treatment and alert the lung pathologist.
First, our patients were heavy smokers, similarly to the
previous published isolated case reports. Second, respira-
tory past history was unremarkable, except unexplained
and severe episodes of hemoptysis in 5 patients, 3 of
whom had received a BAE (Additional file 1). Third,
hemoptysis was massive and presumed to be cryptogenic,
since no cause was identified after physical examination,
fiberoptic bronchoscopy and CT-scan. Conversely to the
gastrointestinal disease for which the endoscopic findings
are diagnostic, we did not use bronchoscopic criteria to
diagnose the vascular disease because the source of bleed-
ing may be difficult to assess during active massive hemo-
ptysis [16-18], the bronchial abnormalities may be sub
segmental and therefore not accessible and the small size
of the bronchial lesion (usually less than 10 mm) may be
difficult to detect when surrounded by clots. However, a
few mucosal abnormalities have been bronchoscopically
described in this setting, such as a smooth elevated non
pulsating lesion [13] or a nodular lesion within a normal
overlying mucosa [9]. It should be emphasized that these
later bronchoscopic findings are not specific and may be
related to bronchial artery aneurysms, arteriovenous mal-
formations or small cancers [19-21]. As the amount of
bleeding related to Dieulafoy disease may be massive,
bronchial biopsies should be avoided in this setting, even
during a period of non active bleeding [9,13]. Moreover,
in our opinion, performing biopsy should be not useful in
this setting, since the diagnosis of Dieulafoy disease of the
bronchus should be based on the pathological examina-
tion of a large surgical lung resection. Fourth, the bron-
chial arteriography findings did neither evidence systemic
to pulmonary shunts nor aneurysms. Additionally, the
arteries appeared all enlarged and frank contrast media
extravasation in the bronchial lumen was frequent, when
combining the findings of both BAE (n = 2) and multide-
tector CT-scan angiography (n = 1). These findings are in
accordance with those reported by Durham et al in gas-
trointestinal Dieulafoy disease [22]. Conversely, little ang-
iographic data are available regarding to the bronchial
artery disease [8-10,12,23,24]. Dilated vessels have been
described [9,10,23], especially in association with specific
parenchymal diseases [10,23]. Last, although no firm con-
clusions can be drawn regarding to the small size of our
population, our study highlights the poor efficacy of BAE
in this clinical setting, as compared with the usual 80% to
90% successful rate of bleeding control using this proce-
dure [17]. Nevertheless, owing to the morbidity and the
mortality related to emergency surgery performed during
active bleeding, we recommend to attempt BAE as the
first-line therapeutic approach [7]. Additionally, some
patients with a non-diagnosed Dieulafoy disease may
have probably been treated with BAE.
To our knowledge, our series is the first to carefully
describe the pathological investigation to diagnose the
Dieulafoy disease of the bronchus on surgical lung resec-
tion. The main pathological criterion is the evidence of a
large and superficial bronchial artery located within the
sub mucosa [8-13]. In our series, the macroscopic analysis
was crucial to detect a minute mucosal defect, as usually
observed in the Dieulafoy disease of the gastrointestinal
tract. As ectopic bronchial arteries have also been
described during chronic pulmonary diseases [17,25,26],
a special attention was made to exclude chronic lung dis-
eases, such bronchiectasis and other inflammatory proc-
esses or carcinoma. Additionally, CT scan demonstrated
no parenchymal abnormalities, except ground glass or
alveolar opacities reflecting the severity of bleeding [27].
Although a few parenchymal abnormalities (blebs, nodu-
lar mass and amyloidal deposit) were pathologically evi-
denced, those later were actually distant from the focal
hemorrhagic area and consequently not considered as the
cause of bleeding.
The pathogenesis of Dieulafoy disease remains unclear.
Whether the origin of the anomaly is congenital, acquired
or merely a variation of normal is not known. As sug-
gested in our study, age and/or tobacco use may be predis-
posing states to the occurrence of the disease. Even if the
dysplastic artery wall change may contribute to its weak-
ness, the trigger factor of the vessel rupture is not known.
Does the vessel rupture occur after a mucosal injury or
does the vessel pressure induce a mucosal defect is
unclear. Furthermore, the nature of the vessel that is
bleeding remains controversial. Some have suggested that
the artery belongs to the pulmonary vasculature owing to
the failure of BAE, while others identified the vessel as
originating from the systemic vasculature [10,13]. In our
series, the angiographic data are supporting this latter
hypothesis, as well as the pathological findings of the ves-
sel with elastic stain and the intravascular evidence of
material of embolization (patient n°4) (Figure 3B). Last,
Dieulafoy disease might be a part of a general disease as
suggested by the clinical history and outcome of the
patient n°4.
The limitations of our study are related to its retrospective
nature and to the fact that it was conducted on patients
undergoing surgery in a referral center with an extensive
experience of severe hemoptysis.Respiratory Research 2008, 9:58 http://respiratory-research.com/content/9/1/58
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In summary, Dieulafoy disease of the bronchus should be
considered in a heavy smoker patient with unexplained
and recurrent massive hemoptysis, after a rigorous con-
frontation of both clinical and radiological findings. Use-
less and dangerous bronchial biopsies should be avoided.
The therapeutic approach should be surgical and the path-
ological examination should be structured and meticu-
lous.
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